Back to Trades
Chen Bihua
Director10% OwnerCIK 0001599214
Total Volume
$140.1M
8 filings
Purchases
$8.0M
1 buy txns
Sales
$46.9M
5 sell txns
Net Activity
-$38.9M
net sold
Profile
- Filings
- 8
- Buy transactions
- 1
- Sell transactions
- 5
- Companies
- 4
- Active
- 2025–2026
Across 8 filings between 2025–2026, Chen Bihua, Director, 10% Owner, has disclosed $140.1M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling — $8.0M in buys and $46.9M in sells. The largest single open-market purchase on record is $8.0M in Helix Acquisition Corp. III. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jul 6 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Director, 10% Owner | Other | $0 |
| Jun 18 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Insider | Award | $244.8K |
| Jan 28 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Buy | $8.0M |
| Jan 26 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Grant | $5.0M |
| Jan 22 | HLXC Helix Acquisition Corp. III | Chen Bihua | Chairperson and CEO, Director, 10% Owner | Other | $0 |
| Oct 1 | MLTX MoonLake Immunotherapeutics | Chen Bihua | Insider | Sell | $46.9M |
| Aug 13 | BBOT BridgeBio Oncology Therapeutics, Inc. | Chen Bihua | Director, 10% Owner | Grant | $75.0M |
| Aug 1 | BMEA Biomea Fusion, Inc. | Chen Bihua | Insider | Other | $0 |
8 filings